Chewable tablet and method for improving abrasion resistance of chewable tablet

Incorporating quercetin glycosides in chewable tablets at specific concentrations and hardness levels addresses abrasion issues while maintaining chewability, enhancing their durability and texture.

WO2026240022A1PCT designated stage Publication Date: 2026-11-19SUNTORY HLDG LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2026/017582
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-15
Filing Date
2026-05-08
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Chewable tablets are prone to abrasion during distribution, leading to reduced weight and appearance issues, and existing methods to enhance abrasion resistance often involve increasing binder content, which may not be desirable.

Method used

Incorporating a predetermined amount of quercetin glycosides (0.5 to 12.0% by weight) and maintaining a hardness of 10.0 to 40.0 kgf in chewable tablets, which can be achieved through direct compression, improves abrasion resistance without significantly increasing binder usage.

Benefits of technology

The tablets exhibit excellent wear resistance and a moderate chewing texture, minimizing damage during handling and providing a pleasant chewing experience.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JPOXMLDOC01-APPB-C000001
    Figure JPOXMLDOC01-APPB-C000001
  • Figure JPOXMLDOC01-APPB-T000002
    Figure JPOXMLDOC01-APPB-T000002
  • Figure JPOXMLDOC01-APPB-T000003
    Figure JPOXMLDOC01-APPB-T000003
Patent Text Reader

Abstract

The purpose of the present invention is to provide a chewable tablet having excellent abrasion resistance and moderate chewiness. The present invention relates to a chewable tablet containing a quercetin glycoside, wherein the content of the quercetin glycoside in terms of quercetin is 0.5-12.0 wt%, and the hardness of the chewable tablet is 10.0-40.0 kgf.
Need to check novelty before this filing date? Find Prior Art

Description

Chewable tablet and method for improving abrasion resistance of chewable tablet

[0001] The present invention relates to a chewable tablet. The present invention also relates to a method for improving the abrasion resistance of a chewable tablet, and the like.

[0002] Chewable tablets can be taken without water and thus are easy to administer, and are used in supplements, foods, pharmaceuticals and the like. Since chewable tablets are usually taken by chewing, they need to have a hardness that allows them to be chewed. On the other hand, chewable tablets have a problem that they are prone to abrasion during distribution processes and the like.

[0003] Quercetin is a type of flavonoid, and is contained in plants such as onions as it is or in the form of glycosides. It has been reported that quercetin and its glycosides have useful physiological activities, and for example, Patent Document 1 describes a salivation promoter containing enzyme-treated isoquercitrin as an active ingredient. Patent Document 1 describes that the content of enzyme-treated isoquercitrin in the salivation promoter is set in the range of 0.001 to 0.5 mass% in terms of α-glucosyl isoquercitrin.

[0004] JP 2017-105774 A

[0005] When a chewable tablet is abraded during a distribution process or the like, the appearance becomes poor. In addition, the weight of the chewable tablet decreases due to abrasion. For the purpose of ingesting a required amount of active ingredient per day, an active ingredient is incorporated into a chewable tablet. However, if the weight of the chewable tablet decreases due to abrasion, the required amount of active ingredient may not be ingested even when a predetermined number of chewable tablets are taken. In the manufacture of tablets, binders are used to improve strength. In order to improve the abrasion resistance of a chewable tablet, it is considered effective to increase the added amount of a binder, but it may be desired to minimize the amount of the binder used. Therefore, a technique capable of improving the abrasion resistance of a chewable tablet by a method other than increasing the amount of a binder is useful. In addition, chewable tablets are usually taken by chewing in the oral cavity, but those with an appropriate chewy texture are sometimes preferred. Patent Document 1 does not describe a method for improving the abrasion resistance or chewy texture of a chewable tablet.

[0006] The present invention aims to provide a chewable tablet that has excellent wear resistance and a moderate chewing sensation.

[0007] The inventors have found that if a chewable tablet contains a predetermined amount of quercetin glycoside and its hardness is within a predetermined range, the abrasion resistance and chewiness of the chewable tablet can be improved. It has not been previously reported that quercetin glycosides have the effect of improving the abrasion resistance and chewiness of tablets.

[0008] The present invention includes the following chewable tablets, etc.: [1] A chewable tablet containing a quercetin glycoside, wherein the quercetin glycoside content, in terms of quercetin, is 0.5 to 12.0% by weight, and the hardness is 10.0 to 40.0 kgf. [2] The chewable tablet according to [1] above, wherein the quercetin glycoside content, in terms of quercetin, is 1.5 to 9.0% by weight. [3] The chewable tablet according to [1] or [2] above, wherein the moisture content is 1.0 to 10.0% by weight. [4] The chewable tablet according to any one of [1] to [3] above, wherein the hardness is 15.0 to 25.0 kgf. [5] The chewable tablet according to any one of [1] to [4] above, which is a direct-compression tablet. [6] A chewable tablet according to any one of [1] to [5] above, wherein the weight per tablet is 300 to 3000 mg. [7] A chewable tablet according to any one of [1] to [6] above, wherein the tablet is disc-shaped with a diameter of 7 to 30 mm. [8] A method for improving the wear resistance of a chewable tablet, wherein the chewable tablet contains 0.5 to 12.0% by weight of quercetin glycoside in terms of quercetin. [9] A use of quercetin glycoside for improving the wear resistance of a chewable tablet, wherein the chewable tablet contains 0.5 to 12.0% by weight of quercetin glycoside in terms of quercetin.

[0009] According to the present invention, it is possible to provide a chewable tablet that has excellent wear resistance and a moderate chewing texture.

[0010] The chewable tablets of the present invention contain a quercetin glycoside, with a quercetin content of 0.5 to 12.0% by weight and a hardness of 10.0 to 40.0 kgf. A chewable tablet refers to a tablet that is taken by chewing. Chewable tablets are also called edible tablets. The chewable tablets of the present invention have excellent abrasion resistance due to containing 0.5 to 12.0% by weight of quercetin glycoside in quercetin equivalent and having a hardness within the above range. Therefore, the chewable tablets of the present invention are less prone to damage or abrasion during manufacturing and transportation. In addition, the chewable tablets of the present invention have a moderate chewing sensation when taken.

[0011] In this specification, quercetin glycosides refer to glycosides of quercetin, which is a compound belonging to the flavonol group, a type of polyphenol. Specifically, quercetin glycosides are a general term for a series of compounds in which one or more sugars (for example, 1 to 10) are glycosidically bonded to the hydroxyl group at position 3 and / or position 4' of quercetin. Quercetin glycosides may consist of one compound or two or more compounds.

[0012] In one embodiment, a quercetin glycoside is preferred in which one or more sugars are glycosidically bonded to the hydroxyl group at position 3 of quercetin. A quercetin glycoside in which one or more sugars are glycosidically bonded to the hydroxyl group at position 3 of quercetin is a compound represented by the following general formula. In the following general formula, (X) n X represents a sugar chain. X represents a sugar (monosaccharide), and n is an integer greater than or equal to 1 (for example, 1 to 10).

[0013]

[0014] The sugar (monosaccharide) constituting the sugar chain represented by X, which is glycosidically bonded to quercetin, is, for example, glucose, rhamnose, galactose, glucuronic acid, etc., preferably glucose and rhamnose, and more preferably glucose. The sugar bonded to quercetin may be modified (e.g., malonylated). Also, n is not particularly limited as long as it is 1 or more, but is preferably 1 to 16, more preferably 1 to 13, and even more preferably 1 to 10. When n is 2 or more, the X portion may consist of one type of sugar or multiple types of sugars. In other words, when n is 2 or more, (X) n This may be a sugar chain consisting of one type of sugar, or it may be a sugar chain consisting of multiple types of sugars.

[0015] In the present invention, quercetin glycosides include existing quercetin glycosides that have been transglycosylated by treatment with enzymes or the like. Examples of quercetin glycosides in the present invention include rutin (quercetin 3-rutinoside), enzyme-treated rutin (enzyme-treated rutin), quercitrin (quercetin-3-O-rhamnoside), isoquercitrin (quercetin 3-glucoside), quercetin 3,4'-diglucoside, quercetin 4'-glucoside, quercetin 3-(6-malonylglucoside), hyperoside (quercetin 3-galactoside), and quercetin-3-O-glucuronide. Enzyme-treated rutin is a quercetin glycoside in which an additional sugar chain is attached to the glucoside portion of isoquercitrin. Preferred examples of enzyme-treated rutin include isoquercitrin, which is obtained by enzymatically treating rutin to remove the rhamnose sugar chain portion, and then treating isoquercitrin with a glycosyltransferase, resulting in isoquercitrin to which a sugar chain consisting of 1 to 7 glucose molecules is attached, and mixtures thereof as the main components. In the present invention, the quercetin glycoside is preferably at least one selected from the group consisting of isoquercitrin and glycosides to which a sugar chain consisting of 1 to 9 glucose molecules is attached. In one embodiment, as the quercetin glycoside, a glycoside in which a sugar chain consisting of 1 to 7 glucose molecules is attached to the hydroxyl group at position 3 of quercetin is more preferred.

[0016] In this invention, one compound may be used alone as the quercetin glycoside, or two or more compounds may be used in combination. When two or more compounds are used in combination as the quercetin glycoside, the quercetin glycoside content is the sum of the content of the two or more compounds.

[0017] In the present invention, there are no particular restrictions on the source or method of obtaining quercetin glycosides. For example, plants that are rich in quercetin glycosides include buckwheat, Japanese pagoda tree, capers, apples, tea, onions, grapes, broccoli, molokhia, raspberries, cranberries, Opuntia, Rhodiola rosea, leafy vegetables, and citrus fruits, and quercetin glycosides can be obtained from these plants. In the present invention, as quercetin glycosides, as long as the effects of the present invention are not impaired, extracts derived from natural products such as the above-mentioned plants can be concentrated, purified, etc., to increase the quercetin glycoside content, for example, concentrated or purified extracts containing quercetin glycosides can be used. Known methods can be used for concentration or purification. In the present invention, purified or isolated quercetin glycosides may be used. Raw materials containing quercetin glycosides may be used. Chemically synthesized quercetin glycosides can also be used.

[0018] The quercetin glycoside content in the raw material containing quercetin glycoside is not particularly limited, but is preferably 10 to 100% by weight, more preferably 15 to 50% by weight, and more specifically, may be 15%, 30%, or 40% by weight. Examples of commercially available products that can be used as quercetin glycoside include San-Emic (manufactured by San-Ei Gen F.F.I. Co., Ltd.).

[0019] In the chewable tablets of the present invention, the quercetin glycoside content is 0.5 to 12.0% by weight in terms of quercetin. When the quercetin glycoside content in the chewable tablets is 0.5% by weight or more in terms of quercetin, the abrasion resistance and chewiness of the chewable tablets can be improved. Furthermore, when the quercetin glycoside content in the chewable tablets is 12.0% by weight or less in terms of quercetin, the chewable tablets have a moderate chewiness and are easy to chew (easy to crush) when taken. The quercetin glycoside content in the chewable tablets of the present invention, in terms of quercetin, is preferably 0.7% by weight or more, more preferably 1.0% by weight or more, even more preferably 1.5% by weight or more, even more preferably 2.0% by weight or more, even more preferably 2.1% by weight or more, particularly preferably 2.5% by weight or more, most preferably 2.7% by weight or more, and also preferably 10.0% by weight or less, more preferably 9.0% by weight or less, even more preferably 8.8% by weight or less, even more preferably 6.0% by weight or less, particularly preferably 5.9% by weight or less. In one embodiment, the quercetin glycoside content in the chewable tablets of the present invention, in terms of quercetin, is preferably 0.7 to 10.0% by weight, more preferably 1.0 to 10.0% by weight, even more preferably 1.5 to 9.0% by weight, even more preferably 2.0 to 8.8% by weight, even more preferably 2.1 to 6.0% by weight, particularly preferably 2.5 to 6.0% by weight, most preferably 2.7 to 5.9% by weight.

[0020] The quercetin content of quercetin glycosides can be measured, for example, by high-performance liquid chromatography (HPLC). Specifically, for example, by HPLC, it is possible to detect peaks originating from quercetin glycosides and calculate the quercetin content from the total area of ​​these peaks. In this specification, the quercetin content of quercetin glycosides or similar expressions means the value obtained by multiplying the number of moles of quercetin glycosides by the molecular weight of quercetin.

[0021] In the chewable tablets of the present invention, the quercetin glycoside content is preferably 2.0% by weight or more, more preferably 2.5% by weight or more, even more preferably 3.0% by weight or more, even more preferably 5.0% by weight or more, particularly preferably 7.0% by weight or more, most preferably 8.0% by weight or more, and also preferably 45.0% by weight or less, more preferably 40.0% by weight or less, even more preferably 35.0% by weight or less, even more preferably 30.0% by weight or less, particularly preferably 25.0% by weight or less, and most preferably 20.0% by weight or less. In one embodiment, the quercetin glycoside content in the chewable tablets of the present invention is preferably 2.0 to 45.0% by weight, more preferably 2.5 to 40.0% by weight, even more preferably 3.0 to 35.0% by weight, even more preferably 5.0 to 30.0% by weight, particularly preferably 7.0 to 25.0% by weight, and most preferably 8.0 to 20.0% by weight.

[0022] In the chewable tablets of the present invention, the amount of quercetin glycoside in the daily intake (dosage) per adult per 60 kg of body weight is not particularly limited, but is preferably 0.1 mg to 8000 mg in terms of quercetin equivalent, more preferably 0.3 mg to 4000 mg, even more preferably 1.0 mg to 1000 mg, even more preferably 10 mg to 500 mg, and particularly preferably 30 mg to 250 mg. Multiple chewable tablets of the present invention may be taken at one time. They can also be taken multiple times a day.

[0023] The chewable tablets of the present invention may contain any additives and components in addition to quercetin glycoside, as long as the effects of the present invention are not impaired. These additives and components may be those that are generally usable in chewable tablets, and examples include functional components other than quercetin glycoside, excipients, fluidizers, lubricants, binders, disintegrants, sweeteners, acidulants, antioxidants, colorants, and flavorings. The chewable tablets of the present invention may contain only one of these additives and components alone, or two or more in combination.

[0024] In one embodiment, the chewable tablet of the present invention can use as little binder as possible, but may contain a binder. Examples of binders include microcrystalline cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, etc., with microcrystalline cellulose being preferred. The binder content in the chewable tablet is preferably 0 to 50.0% by weight, and more preferably 1.0 to 20.0% by weight. In one embodiment, the chewable tablet of the present invention preferably contains 1.0 to 20.0% by weight of microcrystalline cellulose, more preferably 3.0 to 15.0% by weight, and even more preferably 5.0 to 10.0% by weight.

[0025] Examples of functional ingredients other than quercetin glycosides include lactic acid bacteria. Examples of excipients include reduced palatinose, sugar alcohols such as maltitol, and dextrin. Examples of fluidizing agents include silicon dioxide. Examples of lubricants include calcium stearate. Examples of sweeteners include stevia and sucralose. Examples of acidulants include citric acid. If the chewable tablets of the present invention contain any additives or components, their content is not particularly limited and can be in amounts commonly used in chewable tablets.

[0026] In one embodiment, the chewable tablet of the present invention preferably contains a sugar alcohol, and more preferably contains at least one sugar alcohol selected from the group consisting of reduced palatinose and maltitol. If the chewable tablet of the present invention contains a sugar alcohol, the content may be, for example, 40.0 to 90.0% by weight in the chewable tablet, preferably 45.0 to 85.0% by weight, and more preferably 50.0 to 80.0% by weight.

[0027] The chewable tablet of the present invention has a hardness of 10.0 to 40.0 kgf. By containing quercetin glycosides and having a hardness of 10.0 to 40.0 kgf, the chewable tablet has good abrasion resistance and chewiness. The hardness of the chewable tablet of the present invention is preferably 13.0 kgf or more, more preferably 15.0 kgf or more, even more preferably 18.0 kgf or more, and also preferably 38.0 kgf or less, more preferably 35.0 kgf or less, and even more preferably 30.0 kgf or less. In one embodiment of the present invention, the hardness of the chewable tablet may be 19.0 kgf or more, 20.0 kgf or more, 21.0 kgf or more, or 23.0 kgf or more. In one embodiment, the chewable tablet of the present invention has a hardness preferably of 13.0 to 38.0 kgf, more preferably of 15.0 to 38.0 kgf, even more preferably of 18.0 to 35.0 kgf, and particularly preferably of 18.0 to 30.0 kgf. In one embodiment, the hardness of the chewable tablet of the present invention may be 19.0 to 30.0 kgf, 20.0 to 30.0 kgf, 21.0 to 30.0 kgf, or 23.0 to 30.0 kgf. In the present invention, the hardness of the chewable tablet is a value measured by applying a load to the center of the figure when the chewable tablet is viewed from above using a hardness tester. For example, in the case of a disc-shaped or cylindrical chewable tablet, the figure when viewed from above is circular or substantially circular. A commercially available tablet hardness tester capable of measuring the hardness of tablets (for example, a digital hardness tester (KHT-40N, manufactured by Fujiwara Seisakusho Co., Ltd.)) can be used. Measure the hardness of three chewable tablets and use the average value as the hardness.

[0028] The hardness of chewable tablets can be adjusted, for example, by the amount of quercetin glycoside included. The higher the quercetin equivalent content of the quercetin glycoside, the harder the chewable tablet tends to be. The hardness of chewable tablets can also be adjusted by controlling the compression pressure during manufacturing.

[0029] The chewable tablets of the present invention preferably have an abrasion degree of 2.0% by weight or less. The abrasion degree is a value that indicates the abrasion resistance and brittleness of the chewable tablet against impact. An abrasion degree of 2.0% by weight or less is preferable because it indicates good abrasion resistance of the chewable tablet. The abrasion degree of the chewable tablet is more preferably 1.5% by weight or less, and even more preferably 1.0% by weight or less. The abrasion degree can be determined by the following method. Place chewable tablets in a tablet abrasion tester (for example, manufactured by Kayagaki Medical Science Industry Co., Ltd.) so that the weight of the chewable tablets is 3000 mg or more (preferably 3000 to 4000 mg), and rotate for 10 minutes (rotation speed: 25 revolutions / minute). For example, if the weight of one tablet is 1200 mg, place 3 chewable tablets in the tester and rotate for 10 minutes (rotation speed: 25 revolutions / minute). After rotation, brush off any powder from the surface of each tablet (abrasion), and calculate the degree of abrasion using the following formula: Abrasion degree (weight %) = 100 × (Total weight of chewable tablets before rotation (mg) - Total weight of chewable tablets after rotation (mg)) / (Total weight of chewable tablets before rotation (mg))

[0030] The weight per tablet of the chewable tablet of the present invention is not particularly limited. The weight per tablet of the chewable tablet of the present invention may be 300 mg or more, preferably 600 mg or more, more preferably 1000 mg or more, and may be 3000 mg or less, preferably 2400 mg or less, and more preferably 1500 mg or less. In one embodiment, the weight per tablet of the chewable tablet of the present invention may be 300 to 3000 mg, preferably 600 to 2400 mg, and more preferably 1000 to 1500 mg.

[0031] The shape of the chewable tablet of the present invention is not particularly limited and may be, for example, disc-shaped, cylindrical, spherical, etc., but is preferably disc-shaped. When the chewable tablet of the present invention is disc-shaped, cylindrical, or spherical, its diameter is not particularly limited, but may be 7 mm or more, preferably 10 mm or more, more preferably 12 mm or more, and may be 30 mm or less, preferably 20 mm or less, and more preferably 18 mm or less. In one embodiment, when the chewable tablet of the present invention is disc-shaped, cylindrical, or spherical, its diameter may be 7 to 30 mm, preferably 10 to 20 mm, and more preferably 12 to 18 mm.

[0032] When the chewable tablet of the present invention is disc-shaped or cylindrical, its thickness (height) is not particularly limited, but may be 2 mm or more, preferably 4 mm or more, more preferably 6 mm or more, and may be 20 mm or less, preferably 10 mm or less, and more preferably 8 mm or less. In one embodiment, when the chewable tablet of the present invention is disc-shaped or cylindrical, its thickness (height) may be 2 to 20 mm, preferably 4 to 10 mm, and more preferably 6 to 8 mm. When the chewable tablet of the present invention is disc-shaped or cylindrical and its thickness (height) differs depending on the measurement location, the thickness (height) of the chewable tablet refers to the maximum thickness (height).

[0033] When the chewable tablet of the present invention is disc-shaped or cylindrical, the ratio of diameter to thickness (height) (diameter / thickness (height)) is not particularly limited, but may be 0.35 or more, preferably 0.70 or more, more preferably 0.88 or more, even more preferably 1 or more, and may be 15 or less, preferably 7.5 or less, and even more preferably 5 or less. In one embodiment, when the chewable tablet of the present invention is disc-shaped or cylindrical, the ratio of diameter to thickness (height) (diameter / thickness (height)) may be 0.35 to 15, preferably 0.70 to 7.5, more preferably 0.88 to 5, and even more preferably 1 to 5.

[0034] The moisture content of the chewable tablets of the present invention is not particularly limited, but is preferably 1.0% by weight or more, more preferably 2.0% by weight or more, even more preferably 3.0% by weight or more, particularly preferably 4.0% by weight or more, and also preferably 10% by weight or less, more preferably 8.0% by weight or less, and even more preferably 5.0% by weight or less. In one embodiment, the moisture content of the chewable tablets of the present invention is preferably 1.0 to 10.0% by weight, more preferably 2.0 to 8.0% by weight, even more preferably 3.0 to 5.0% by weight, and particularly preferably 4.0 to 5.0% by weight. A moisture content within the above range is preferable because it results in higher wear resistance. The moisture content of the chewable tablets can be determined by drying the chewable tablets and measuring the weight loss. Specifically, the moisture content can be determined by the method described in the examples.

[0035] The method for manufacturing the chewable tablets of the present invention is not particularly limited. For example, the tablets can be manufactured by mixing quercetin glycosides with any additives and components such that the quercetin content of the quercetin glycosides in the resulting mixture is 0.5 to 12.0% by weight, and then molding the resulting mixture. In the chewable tablets of the present invention, the method and conditions for mixing quercetin glycosides with any additives and components, and the method and conditions for molding the resulting mixture into chewable tablets are not particularly limited as long as the hardness of the resulting chewable tablets is 10.0 to 40.0 kgf. Methods and conditions known in the art can be appropriately adopted. For example, methods for molding the chewable tablets of the present invention include direct compression, semi-direct compression, wet granule compression, and dry granule compression. In one embodiment, the chewable tablets of the present invention are preferably direct compression tablets. A direct compression tablet refers to a tablet obtained by the direct compression method. By having a quercetin glycoside content equivalent to 0.5 to 12.0% by weight, the hardness of tablets obtained by the direct compression method can be set to 10.0 to 40.0 kgf. Tableting can be performed using a general tableting apparatus used in the manufacture of tablets. For example, in the case of chewable tablets with a diameter of 7 to 30 mm, the compression pressure during tableting is preferably 2 to 13 kN, more preferably 8 to 13 kN, even more preferably 11 to 13 kN, and particularly preferably 12 to 13 kN.

[0036] The recipients of the chewable tablets of the present invention (which can also be called the recipients of administration) are not particularly limited. Preferably, they are humans or non-human mammals, and more preferably humans. The chewable tablets of the present invention may be general foods, health foods, foods with functional claims, foods for specified health uses, health supplements, foods and beverages for sick people, etc.

[0037] Quercetin glycosides can be used to improve the wear resistance of chewable tablets. The present invention also includes a method for improving the wear resistance of chewable tablets by incorporating 0.5 to 12.0% by weight of quercetin glycosides in terms of quercetin into the chewable tablets. The present invention also includes the use of quercetin glycosides to improve the wear resistance of chewable tablets, wherein 0.5 to 12.0% by weight of quercetin glycosides in terms of quercetin into the chewable tablets. In the method and use of the present invention, it is preferable to adjust the hardness of the chewable tablets to 10.0 to 40.0 kgf. By including 0.5 to 12.0% by weight of quercetin glycosides in the chewable tablets, and adjusting the hardness of the chewable tablets to 10.0 to 40.0 kgf, the wear resistance and chewiness of the chewable tablets can be improved. Preferred embodiments of the chewable tablets, such as the quercetin glycoside content and the hardness of the chewable tablets, are the same as those of the chewable tablets of the present invention described above.

[0038] In this specification, a numerical range expressed by a lower limit and an upper limit, i.e., "lower limit to upper limit," includes those lower and upper limits. For example, a range expressed as "1 to 2" means 1 or more and 2 or less, including 1 and 2. In this specification, the upper and lower limits may be any combination of ranges. All academic and patent documents mentioned in this specification are incorporated herein by reference.

[0039] The present invention will be described more specifically below based on examples. However, the present invention is not limited to these examples.

[0040] <Ingredients Used> The following ingredients were used in the following examples and comparative examples: Quercetin glycoside A (a mixture of two or more quercetin glycosides in which 1 to 7 glucose molecules are attached to the hydroxyl group at position 3 of quercetin; quercetin content of quercetin glycosides in terms of quercetin: 29.3% by weight) Microcrystalline cellulose (Ceolus UF-F711, manufactured by Asahi Kasei Corporation) Sugar alcohol (Palatinite® PNM-2, reduced palatinose manufactured by DM Mitsui Sugar Co., Ltd.)

[0041] <Examples 1 to 10 and Comparative Examples 1 to 6> Each raw material was mixed so as to achieve the compositions (% by weight) shown in Tables 1 to 3 below, to prepare a mixture (mixed powder). The obtained mixture was tableted using a tablet press (desktop prototype tablet press FY-MMP2-30, manufactured by Fuji Yakuhin Kikai Co., Ltd.) under the tableting conditions shown in Tables 1 to 3, to obtain disk-shaped chewable tablets with a diameter of 15 mm, a thickness of 7 mm, and a weight of 1200 mg per tablet. In Tables 1 to 3, "the content of quercetin glycoside in terms of quercetin" indicates the content (% by weight) of quercetin glycoside in terms of quercetin contained in the chewable tablets.

[0042]

[0043]

[0044]

[0045] The hardness, friability and moisture content of the chewable tablets obtained in the Examples and Comparative Example 1 were measured. In addition, the chewiness of the chewable tablets of Examples 1 to 7 and Comparative Examples 1 to 6 was evaluated.

[0046] (Measurement of Hardness) The hardness of the chewable tablets was measured using a hardness tester (digital hardness tester KHT-40N, manufactured by Fujiwara Seisakusho Co., Ltd.). The tablet was placed such that the measurement site contacted the center of the upper surface of the chewable tablet, a load was applied, and the load value (kgf) when the chewable tablet broke was taken as the measured hardness value of the chewable tablet. Three chewable tablets were measured, and the average value of the measured hardness values was taken as the evaluation value. The hardness (evaluation value) of the chewable tablets is shown in Table 4.

[0047]

[0048] (Measurement of Friability) Three chewable tablets were placed in a tablet friability tester (manufactured by Kayagi Irika Kogyo Co., Ltd.) and rotated for 10 minutes (rotation speed: 25 rotations / minute). After the rotation was completed, the powder on the surface of the chewable tablets was brushed off with a brush for cleaning an analytical balance, and the friability was calculated by the following formula. Friability (% by weight) = 100 × (total weight of chewable tablets before rotation (mg) - total weight of chewable tablets after rotation (mg)) / (total weight of chewable tablets before rotation (mg)) The friability (% by weight) is shown in Table 5. The target for friability was 2.0% by weight or less.

[0049]

[0050] The chewable tablets of Examples 1 to 10 had an abrasion rate of 2.0% by weight or less. For example, Examples 1 to 7 and Comparative Example 1 were chewable tablets manufactured under the same tableting conditions. A comparison between Comparative Example 1 and Examples 1 to 7 showed that the abrasion resistance of the chewable tablets improved by including quercetin glycosides. Furthermore, from Example 8 onwards, when the chewable tablets contained quercetin glycosides and had a hardness of 10.0 to 40.0 kgf, they exhibited better abrasion resistance than Comparative Example 1, even without the inclusion of a binder.

[0051] (Measurement of moisture content) The moisture content was determined by drying the sample and measuring the weight loss. Five chewable tablets were crushed into a powder in a mortar and pestle to prepare the sample. Approximately 5 g of the sample (crushed chewable tablets) was weighed out, and the moisture content was measured using an infrared moisture meter FD-720 (manufactured by Kett Scientific Research Institute Co., Ltd.) under drying conditions of 80°C for 20 minutes. The moisture content (weight %) is calculated using the following formula: Moisture content (weight %) = 100 × (weight of sample before drying - weight of sample after drying) / (weight of sample before drying) The results are shown in Table 6. The moisture content of the chewable tablets increased due to the presence of quercetin glycosides.

[0052]

[0053] (Evaluation of the chewiness of the chewable tablets) The chewiness of the chewable tablets of Examples 1-7 and Comparative Examples 1-6 was evaluated by three panelists (Panelists A-C) in their 30s and 40s who had received training in sensory evaluation, using the following method. One chewable tablet was placed in the mouth and chewed for about 10 seconds until it could be swallowed. The chewiness was evaluated on a scale of 1 to 5 points (5 levels) according to the following criteria. A score of 3 indicates good chewiness as a chewable tablet. Before evaluation, it was confirmed that there were no significant differences in the chewiness scores among the panelists. As a baseline, the chewiness of the chewable tablet of Comparative Example 1 was set at 1 point, and the chewiness of the chewable tablet of Comparative Example 5 was set at 5 points.

[0054] Chewing Texture Rating Criteria 1 point: Soft as a chewable tablet 2 points: Slightly soft as a chewable tablet 3 points: Moderately hard as a chewable tablet 4 points: Slightly hard as a chewable tablet 5 points: Hard as a chewable tablet

[0055] The results are shown in Table 7. The results are shown as the average score of the three panelists. The chewable tablet in Comparative Example 6 was too hard to chew.

[0056]

[0057] Comparing Comparative Examples 1-3 with the Example, the chewable tablets of the Example had a better chewing texture than the Comparative Examples. Comparative Examples 4-6 were too hard and difficult to chew. The chewable tablets of the Example contained 0.5-12.0% by weight of quercetin glycosides in terms of quercetin, and had a hardness of 10.0-40.0 kgf, resulting in improved abrasion resistance and a good chewing texture.

[0058] <Manufacturing Example 1> Quercetin glycoside A, microcrystalline cellulose, and sugar alcohol (reduced palatinose) were mixed to prepare a mixture with the same composition as Example 4 in Table 1 (containing 10.0% by weight of quercetin glycoside A, 10.0% by weight of microcrystalline cellulose, and 80.0% by weight of sugar alcohol). Using the obtained mixture, tablets were compressed in a tablet press to obtain a hardness of 20.0 kgf, resulting in disc-shaped chewable tablets with a diameter of 7 mm. Also, using the above mixture, tablets were compressed in a tablet press to obtain a hardness of 20.0 kgf, resulting in disc-shaped chewable tablets with a diameter of 30 mm. When the chewability of the obtained chewable tablets was evaluated, it was found to be good.

Claims

1. A chewable tablet containing quercetin glycosides, wherein the quercetin glycoside content (in quercetin equivalent) is 0.5 to 12.0% by weight, and the hardness is 10.0 to 40.0 kgf.

2. The chewable tablet according to claim 1, wherein the quercetin glycoside content, in terms of quercetin equivalent, is 1.5 to 9.0% by weight.

3. A chewable tablet according to claim 1 or 2, wherein the moisture content is 1.0 to 10.0% by weight.

4. A chewable tablet according to claim 1 or 2, wherein the hardness is 15.0 to 25.0 kgf.

5. A chewable tablet according to claim 1 or 2, wherein it is a direct-compression tablet.

6. A chewable tablet according to claim 1 or 2, wherein the weight per tablet is 300 to 3000 mg.

7. The chewable tablet according to claim 1 or 2, which is disc-shaped with a diameter of 7 to 30 mm.

8. A method for improving the wear resistance of chewable tablets, comprising containing 0.5 to 12.0% by weight of quercetin glycosides in terms of quercetin.

9. Use of quercetin glycosides to improve the wear resistance of chewable tablets, wherein the chewable tablets contain 0.5 to 12.0% by weight of quercetin glycosides in terms of quercetin.